Dec 19 (Reuters) - BioMarin Pharmaceutical (BMRN) said on Friday it would acquire Amicus Therapeutics (FOLD) for about $4.8 billion, expanding its presence in rare metabolic diseases.
The drugmaker will pay $14.50 per share for Amicus, a premium of 33.1% to the stock's last close. Shares of Amicus surged 30%, while BioMarin rose nearly 5% in premarket trading.
The deal strengthens BioMarin's portfolio with Amicus' approved genetic disorder treatments including Galafold, an oral drug for Fabry disease, which is caused by a faulty gene that leads to a buildup of fatty substances in cells.
Amicus also markets a combination therapy Pombiliti and Opfolda for Pompe disease, a genetic condition in which a complex sugar called glycogen builds up in the body's cells.
Amicus also has U.S. rights to DMX-200, a potential treatment of a type of kidney disease known as focal segmental glomerulosclerosis.
BioMarin intends to finance the deal through a combination of cash on hand and about $3.7 billion of non-convertible debt financing.
The company's total cash and investments at the end of September 30 were about $2 billion.
The acquisition, which is expected to close in the second quarter of 2026, will add revenue immediately after the transaction closes, BioMarin said.
The deal is also expected to add to adjusted profit in the first 12 months after close and be substantially accretive beginning in 2027, the company said.
(Reporting by Christy Santhosh and Sriparna Roy in Bengaluru; Editing by Leroy Leo and Maju Samuel)
LATEST POSTS
- 1
Airport wait times won't return to normal until Congress reaches a deal to pay TSA. Here's why they still can't come to an agreement. - 22024 Watch Gathering: The Best Watches of the Year
- 3Track down the Ideal Weight reduction Methodology for Your Way of life
- 4Birutė Galdikas: The last of the ‘angels’ in primatology’s most extraordinary chapter
- 5Defence chiefs of Thailand and Cambodia to discuss ceasefire
- Minute Maid’s frozen juice concentrate is ending after 80 years — and so is a certain kind of kitchen ritual
- How to get tickets for AC/DC's 2026 'Power Up' Tour
- California officials warn against foraging wild mushrooms after deadly poisoning outbreak
- Audits of 6 European Busssiness Class Flights
- Vaccine exemptions for religious or personal beliefs are rising across the U.S.
- From Certificate to Dollars: College Majors with Extraordinary Monetary Prizes
- Etymological Experiences on the Wireless transmissions: A Survey of \Learning in a hurry\ Language Web recording
- Seoul says sorry after unapproved drone flights into North Korea
- Thousands of genomes reveal the wild wolf genes in most dogs’ DNA
